AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)
CUSIP: 03152W109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 312,579,912
- Total 13F shares
- 315,168,068
- Share change
- -6,515,796
- Total reported value
- $3,126,533,611
- Put/Call ratio
- 101%
- Price per share
- $9.92
- Number of holders
- 256
- Value change
- -$75,738,128
- Number of buys
- 137
- Number of sells
- 108
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
28,204,309
|
$332,246,759 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
9%
|
28,057,456
|
$330,516,832 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.8%
|
27,400,000
|
$322,772,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.3%
|
22,849,449
|
$269,166,511 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6%
|
18,803,645
|
$221,506,938 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
5%
|
15,691,157
|
$184,841,838 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.4%
|
13,814,514
|
$162,712,883 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
4.2%
|
13,257,286
|
$156,170,829 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
12,442,501
|
$146,572,662 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.7%
|
11,526,279
|
$135,779,567 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3.1%
|
9,704,848
|
$114,323,110 | — | 31 Mar 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
3%
|
9,344,102
|
$110,073,522 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.3%
|
7,070,733
|
$83,293,000 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.2%
|
6,767,373
|
$79,865,954 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
6,210,736
|
$73,172,564 | — | 31 Mar 2024 | |
| Fiera Capital Corp |
13F
|
Company |
1.7%
|
5,222,329
|
$61,519,036 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.5%
|
4,800,899
|
$56,554,590 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
4,359,326
|
$51,352,860 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.4%
|
4,351,081
|
$51,255,734 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
3,156,082
|
$37,178,645 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.85%
|
2,641,537
|
$31,117,306 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
0.8%
|
2,500,000
|
$29,450,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.79%
|
2,482,403
|
$29,242,707 | — | 31 Mar 2024 | |
| Blackstone Inc. |
13F
|
Company |
0.79%
|
2,467,104
|
$29,062,486 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.74%
|
2,326,927
|
$27,411,200 | — | 31 Mar 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.7%
|
2,176,600
|
$25,640,348 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.62%
|
1,928,842
|
$22,721,759 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.56%
|
1,747,546
|
$20,586,092 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.52%
|
1,622,399
|
$19,111,861 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.5%
|
1,550,315
|
$18,262,711 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.49%
|
1,547,141
|
$18,225,321 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.49%
|
1,529,162
|
$18,013,528 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.48%
|
1,495,500
|
$17,616,990 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.44%
|
1,389,361
|
$16,368,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.43%
|
1,351,182
|
$15,916,924 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
1,341,890
|
$15,807,464 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
1,313,170
|
$15,469,143 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.37%
|
1,163,050
|
$13,700,728 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.37%
|
1,152,656
|
$13,578,288 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
1,147,544
|
$13,518,068 | — | 31 Mar 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.35%
|
1,094,200
|
$12,889,676 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.34%
|
1,052,009
|
$12,392,800 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.33%
|
1,028,569
|
$12,116,543 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.32%
|
1,011,776
|
$11,918,721 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.31%
|
956,200
|
$11,264,000 | — | 31 Mar 2024 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.29%
|
918,834
|
$10,823,865 | — | 31 Mar 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.29%
|
898,381
|
$10,582,928 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
897,896
|
$10,577,215 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.26%
|
802,500
|
$9,453,450 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.26%
|
799,823
|
$9,421,915 | — | 31 Mar 2024 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2024
As of 30 Jun 2024,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
256 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
315,168,068 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, JANUS HENDERSON GROUP PLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, and Redmile Group, LLC.
This page lists
256
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
253
Q2 2024 holders
256
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.